FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1541757900> ?p ?o ?g. }

• W1541757900 endingPage "400" @default.
• W1541757900 startingPage "393" @default.
• W1541757900 abstract "In a single‐centre study the feasibility and efficacy of repeated antilymphocyte globulin (ALG) for patients with severe aplastic anaemia (SAA) not responding to an initial ALG treatment or relapsing after initial response to ALG was evaluated. 139 consecutive patients with newly diagnosed SAA were treated with ALG between 1976 and 1995. 89 patients responded to a first course; 50 patients did not become transfusion independent. Of the 89 responders, 66 remained in remission, 23 relapsed. 43 patients received a second or subsequent course of ALG for failure to respond ( n = 25) or relapse ( n = 18) and were given a total of 53 courses. Acute reactions in the multiply exposed patients occurred during the first ALG treatment in 11 (26%) and during subsequent exposures in 16/53 courses (30%; P > 0.2). Incidence of serum sickness was 63% (27/43) after the initial course compared to 57% (30/53) after subsequent courses ( P > 0.2), but clinical signs of serum sickness occurred earlier after repeated (median 6 d) as compared to initial exposure (13 d; P = 0.008). Transfusion‐independent haemopoiesis was achieved in 27/43 (63%) and survival probabilities for the 43 patients receiving multiple courses of ALG was 52 ± 8% at 10 years. The probability of developing a late clonal disorder was 53 ± 10% after multiple, as compared to 34 ± 7% after single exposure ( P = 0.15). No difference in results was observed between patients retreated for failure to first ALG or for relapse. ALG of the same species can be repeated without increased risks of side‐effects in patients with SAA. A second or subsequent course of ALG from the same source can be effective when the first course has failed." @default.
• W1541757900 created "2016-06-24" @default.
• W1541757900 creator A5004985873 @default.
• W1541757900 creator A5007751978 @default.
• W1541757900 creator A5010990894 @default.
• W1541757900 creator A5046258011 @default.
• W1541757900 creator A5067794169 @default.
• W1541757900 creator A5072582820 @default.
• W1541757900 creator A5079480540 @default.
• W1541757900 creator A5084352990 @default.
• W1541757900 creator A5090405271 @default.
• W1541757900 date "1998-02-01" @default.
• W1541757900 modified "2023-10-17" @default.
• W1541757900 title "Repeated treatment with horse antilymphocyte globulin for severe aplastic anaemia" @default.
• W1541757900 cites W105676805 @default.
• W1541757900 cites W1494325974 @default.
• W1541757900 cites W1523100198 @default.
• W1541757900 cites W157352794 @default.
• W1541757900 cites W1851142847 @default.
• W1541757900 cites W196567407 @default.
• W1541757900 cites W1966890120 @default.
• W1541757900 cites W1967178961 @default.
• W1541757900 cites W1967528790 @default.
• W1541757900 cites W1983696710 @default.
• W1541757900 cites W1983705969 @default.
• W1541757900 cites W1987922702 @default.
• W1541757900 cites W1988062919 @default.
• W1541757900 cites W1993411007 @default.
• W1541757900 cites W2004203951 @default.
• W1541757900 cites W2005518037 @default.
• W1541757900 cites W2032388436 @default.
• W1541757900 cites W2038252730 @default.
• W1541757900 cites W2039738259 @default.
• W1541757900 cites W2050058791 @default.
• W1541757900 cites W2050239182 @default.
• W1541757900 cites W2055023639 @default.
• W1541757900 cites W2055482423 @default.
• W1541757900 cites W2069757957 @default.
• W1541757900 cites W2071159074 @default.
• W1541757900 cites W2074672006 @default.
• W1541757900 cites W2083048416 @default.
• W1541757900 cites W2100500317 @default.
• W1541757900 cites W2171955226 @default.
• W1541757900 cites W2319873259 @default.
• W1541757900 cites W2341016096 @default.
• W1541757900 cites W3114028392 @default.
• W1541757900 cites W3117239408 @default.
• W1541757900 cites W33744869 @default.
• W1541757900 cites W4241658885 @default.
• W1541757900 cites W4242724687 @default.
• W1541757900 cites W4293241248 @default.
• W1541757900 cites W47086436 @default.
• W1541757900 cites W65417936 @default.
• W1541757900 doi "https://doi.org/10.1046/j.1365-2141.1998.00578.x" @default.
• W1541757900 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9488634" @default.
• W1541757900 hasPublicationYear "1998" @default.
• W1541757900 type Work @default.
• W1541757900 sameAs 1541757900 @default.
• W1541757900 citedByCount "93" @default.
• W1541757900 countsByYear W15417579002012 @default.
• W1541757900 countsByYear W15417579002013 @default.
• W1541757900 countsByYear W15417579002014 @default.
• W1541757900 countsByYear W15417579002015 @default.
• W1541757900 countsByYear W15417579002016 @default.
• W1541757900 countsByYear W15417579002017 @default.
• W1541757900 countsByYear W15417579002018 @default.
• W1541757900 countsByYear W15417579002019 @default.
• W1541757900 countsByYear W15417579002020 @default.
• W1541757900 countsByYear W15417579002021 @default.
• W1541757900 countsByYear W15417579002023 @default.
• W1541757900 crossrefType "journal-article" @default.
• W1541757900 hasAuthorship W1541757900A5004985873 @default.
• W1541757900 hasAuthorship W1541757900A5007751978 @default.
• W1541757900 hasAuthorship W1541757900A5010990894 @default.
• W1541757900 hasAuthorship W1541757900A5046258011 @default.
• W1541757900 hasAuthorship W1541757900A5067794169 @default.
• W1541757900 hasAuthorship W1541757900A5072582820 @default.
• W1541757900 hasAuthorship W1541757900A5079480540 @default.
• W1541757900 hasAuthorship W1541757900A5084352990 @default.
• W1541757900 hasAuthorship W1541757900A5090405271 @default.
• W1541757900 hasBestOaLocation W15417579001 @default.
• W1541757900 hasConcept C120665830 @default.
• W1541757900 hasConcept C121332964 @default.
• W1541757900 hasConcept C126322002 @default.
• W1541757900 hasConcept C141071460 @default.
• W1541757900 hasConcept C151730666 @default.
• W1541757900 hasConcept C159654299 @default.
• W1541757900 hasConcept C203014093 @default.
• W1541757900 hasConcept C2779703309 @default.
• W1541757900 hasConcept C2780007613 @default.
• W1541757900 hasConcept C2780762169 @default.
• W1541757900 hasConcept C2781440808 @default.
• W1541757900 hasConcept C61511704 @default.
• W1541757900 hasConcept C71924100 @default.
• W1541757900 hasConcept C81358767 @default.
• W1541757900 hasConcept C86803240 @default.
• W1541757900 hasConcept C90924648 @default.
• W1541757900 hasConceptScore W1541757900C120665830 @default.

• next